Back Home Back Home
  繁體中文
  HOME SCIENCE GENETIC TESTS NEWS ABOUT US  
 
Genetic Tests
 

Introduction

a simple genetic test can personalize medicine for you and reduce adverse drug reactions?

Adverse Drug Reactions (ADR) describe injurious effects associated with therapeutic drugs at normal dose. Some adverse drug reactions are not very serious, but others cause death, prolong hospitalization, and permanent disability. Millions of people are affected by ADR in the world each year. Although most adverse drug events can be avoided with attentive patient care, some adverse events are difficult to detect or to prevent in a timely manner. More than 1 million Americans are hospitalized due to ADR each year.

Since the completion of the human genome sequences, personalized medicine based on individual’s genomic profiles is now possible. For example, scientists have identified that patients with a specific genetic marker can have over thousand folds increase their chance of severe adverse reason to specific drug. Using a companion genetic IVD test to offer a safer and more effective drug for patients has become a reality. Browse through our website and see if we can help you.

 
  Related to Drug : Abacavir < more >  
  HLA-B* 5701 Detection  
  RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*5701 and Internal Control. Analysis is based on Ct values.  
     
 
  Related to Drug : Allopurinol < more >  
  HLA-B* 5801 Detection  
  RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*5801 and Internal Control. Analysis is based on Ct values. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.  
  HLA-B* 5801 Detection-FastGel  
  PCR based detection method: each sample requires only 1 PCR rxn for detection of HLA-*B 5801 and Internal Control. Analysis is based on gel electrophoresis or Agilent™ BioAnalyzer™.A complete kit version is CE marked.  
     
 
  Related to Drug : Carbamazepine & Phenytoin < more >  
  HLA-B* 1502 Detection  
  RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*1502 and Internal Control. Analysis is based on Ct values. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.  
  HLA-B* 1502 Detection-FastGel  
  PCR based detection method: each sample requires only 1 PCR rxn for detection of HLA-*B 1502 and Internal Control. Analysis is based on gel electrophoresis or Agilent™ BioAnalyzer™. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.  
     
 
  Related to Drug : Carbamazepine < more >  
  HLA-A* 3101 Detection  
  RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-A*3101 and Internal Control. Analysis is based on Ct values.  
     
 
  Related to Drug : Warfarin < more >  
  VKORC1 (-1639) Detection  
  RT-PCR & TaqManR based detection method: each sample requires only 1 PCR rxns for surveying of relevant subtypes of VKORC1 (-1639). GG, GA, & AA subtypes controls are developed to establish the position of GG, GA, & AA subtypes for analysis. Analysis is based on the position of the test sample verses the positions of each subtypes. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.  
  CYP2C9*2 Detection  
  RT-PCR & TaqManR based detection method: each sample requires only 1 PCR rxns for surveying of relevant subtypes of CYP2C9*2 (c.430). CC, CT, & TT subtypes controls are developed to establish the position of CC, CT, & TT subtypes for analysis. Analysis is based on the position of the test sample verses the positions of each subtypes. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.  
  CYP2C9*3 Detection  
  RT-PCR & TaqManR based detection method: each sample requires only 1 PCR rxns for surveying of relevant subtypes of CYP2C9*3 (c.1075). AA, AC, & CC subtypes controls are developed to establish the position of AA, AC, & CC subtypes for analysis. Analysis is based on the position of the test sample verses the positions of each subtypes.A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.  
     
 
 
  Genetic Tests
Abacavir
   - HLA-B*5701 RT-PCR

Allopurinol
   - HLA-B*5801 RT-PCR
   - HLA-B*5801 Gel

Carbamazepine
   - HLA-B*1502 RT-PCR
   - HLA-B*1502 Gel
   - HLA-A*3101 RT-PCR

Phenytoin
   - HLA-B*1502 RT-PCR
   - HLA-B*1502 Gel

Warfarin
   - VKORC1 Test
   - CYP2C9*2 Test
   - CYP2C9*3 Test

 
  Technical Support  
  Pricing & Licensing
   - US customers
   - non-US customers
 
  Hosp./Labs/Partners  
 
 
 
 

About Us      |      Terms & Liability      |      Hosp./Labs/Partners      |      Technical Support

Copyright © 2012 Pharmigene, Inc. All rights reserved.